NCLEX Review Guide: Thrombolytic Medications

How Thrombolytics Work

• Thrombolytics dissolve existing blood clots by converting plasminogen to plasmin, which breaks down fibrin in clots. These medications are also called "clot busters" and work differently from anticoagulants that prevent new clot formation.
• Primary mechanism involves activating the fibrinolytic system to restore blood flow in occluded vessels. The process is time-sensitive, with effectiveness decreasing as clots age and become more organized.

Common Thrombolytic Agents

• Alteplase (tPA) - Most commonly used, tissue-specific with shorter half-life requiring continuous infusion. Used for acute MI, stroke, and pulmonary embolism.
• Streptokinase - Older agent, antigenic properties may cause allergic reactions, longer duration of action. Less commonly used due to side effect profile.
• Reteplase and Tenecteplase - Newer agents with longer half-lives allowing bolus dosing, reducing administration complexity.

Primary Uses

• Acute Myocardial Infarction (STEMI) - Must be given within 12 hours of symptom onset, ideally within 30 minutes of hospital arrival. Door-to-needle time is a critical quality measure.
• Acute Ischemic Stroke - Administration within 3-4.5 hours of symptom onset after ruling out hemorrhagic stroke with CT scan. Neurological assessment is crucial before and after administration.
• Pulmonary Embolism - Reserved for massive PE with hemodynamic compromise when other treatments are insufficient. Risk-benefit analysis is essential due to bleeding risks.

Pre-Administration Assessment

1. Verify indication and confirm no contraindications through thorough history and physical assessment
2. Obtain baseline vital signs, neurological assessment, and laboratory values (CBC, PT/PTT, fibrinogen)
3. Establish two large-bore IV access sites, avoid arterial punctures and unnecessary invasive procedures
4. Calculate correct dosage based on patient weight and specific protocol requirements

During Administration

• Continuous cardiac monitoring required as reperfusion arrhythmias may occur when blood flow is restored to ischemic tissue. Have emergency equipment readily available.
• Monitor for signs of bleeding including neurological changes, hypotension, tachycardia, and decreased hematocrit. Perform frequent neurological assessments every 15 minutes initially.
• Avoid invasive procedures, intramuscular injections, and arterial punctures during and for 24 hours after administration. Use pressure for at least 10 minutes for any necessary venipunctures.

Major Complications

• Hemorrhage is the most serious adverse effect, occurring in 1-5% of patients with intracranial hemorrhage being most feared. Early recognition and immediate intervention are crucial for patient survival.
• Reperfusion arrhythmias occur as blood flow returns to ischemic tissue, including ventricular tachycardia, accelerated idioventricular rhythm, and heart blocks. These often indicate successful reperfusion.
• Allergic reactions more common with streptokinase due to antigenic properties, ranging from mild rash to anaphylaxis requiring immediate treatment with epinephrine and corticosteroids.

Antidotes & Reversal

• Aminocaproic acid and tranexamic acid are antifibrinolytic agents that can reverse thrombolytic effects by inhibiting plasminogen activation.
• Fresh frozen plasma, cryoprecipitate, and platelet transfusions may be necessary to replace clotting factors and control severe bleeding episodes.

Common Pitfalls

• Don't confuse thrombolytics with anticoagulants - thrombolytics dissolve existing clots while anticoagulants prevent new ones
• Remember that reperfusion arrhythmias are often a good sign indicating the medication is working, not necessarily a complication requiring drug discontinuation
• Time windows are critical - stroke has 3-4.5 hour window, MI has 12 hour window, but earlier is always better for optimal outcomes

Quick Assessment Checklist

• ☐ Can you identify signs of bleeding complications?
• ☐ Do you know the difference between thrombolytics and anticoagulants?
• ☐ Can you list absolute contraindications?
• ☐ Do you understand time-critical administration windows?
• ☐ Can you recognize reperfusion arrhythmias?